IF by specialty › Hematology
Seminars in Thrombosis and Hemostasis — Impact Factor
The 2025 Impact Factor of Seminars in Thrombosis and Hemostasis is 4.2 (Q1 in Hematology; subscription or hybrid).
- Impact Factor
- 4.2 JCR 2025
- JCR category
- Hematology
- Quartile
- Q1 in Hematology
- Publisher
- Thieme
- Open access
- subscription or hybrid
- IF source
- thieme-connect.com
Position within the field
Ranked 24 of the 38 journals in Hematology on this site (bottom 50%).
Hematology journals with a similar Impact Factor
- Journal of Cerebral Blood Flow and Metabolism IF 4.7
- Cytotherapy IF 4.5
- Seminars in Hematology IF 4.3
- Clinical Lymphoma Myeloma and Leukemia IF 4.1
- Hematological Oncology IF 4.1
- Current Hematologic Malignancy Reports IF 4.0
About this value
The Journal Impact Factor of Seminars in Thrombosis and Hemostasis (JCR 2025, released June 2026) is 4.2. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Hematology.